Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
15.09
+0.60 (4.14%)
Jun 21, 2024, 12:42 PM EDT - Market open

Inhibrx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year
20232022
Net Income
-154.96-115.33
Depreciation & Amortization
2.962.85
Share-Based Compensation
20.6917.79
Other Operating Activities
2.313.88
Operating Cash Flow
-129.01-90.81
Capital Expenditures
-4.59-0.69
Investing Cash Flow
-4.59-0.69
Other Financing Activities
133.691.5
Financing Cash Flow
133.691.5
Free Cash Flow
-133.6-91.5
Free Cash Flow Margin
-8176.25%-6957.95%
Free Cash Flow Per Share
-9.98-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).